title: Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials.
abstract: In a Perspective, Francisco Beca and Andrew Beck discuss Charles Swanton and colleagues' accompanying Research Article on somatic mutations in patients with inflammatory breast cancer treated in a Phase II clinical trial.
authors.affiliation: Department of Pathology and Cancer Research Institute, Beth Israel Deaconess Cancer Center, Boston, Massachusetts, United States of America.|Harvard Medical School, Boston, Massachusetts, United States of America.
authors.forename: Francisco
authors.identifier: http://orcid.org/0000-0002-4409-012X
authors.initials: F
authors.lastname: Beca
authors.affiliation: Department of Pathology and Cancer Research Institute, Beth Israel Deaconess Cancer Center, Boston, Massachusetts, United States of America.|Harvard Medical School, Boston, Massachusetts, United States of America.
authors.forename: Andrew H
authors.initials: AH
authors.lastname: Beck
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D017322:Clinical Trials, Phase II as Topic; D019143:Evolution, Molecular; D005260:Female; D016678:Genome; D006801:Humans